Compositions pharmaceutiques et leurs procédés d'utilisation

Pharmaceutical compositions and their methods of use

Pharmazeutische zusammensetzungen und verfahren zur verwendung

Patent Citations (22)

    Publication numberPublication dateAssigneeTitle
    US-2004152724-A1August 05, 2004Dart Michael J, Searle Xenia B, Tietje Karin R, Toupence Richard BAzabicyclic compounds are central nervous system active agents
    US-2950707-AAugust 30, 1960Butler Frank DavidCombined liquid fuel and excess air metering and distributing, combined liquid fuel and excess air atomizing and injecting, internal combustion engine
    US-5914328-AJune 22, 1999Abbott LaboratoriesHeterocyclic ether compounds useful in controlling neurotransmitter release
    US-5948793-ASeptember 07, 1999Abbott Laboratories3-pyridyloxymethyl heterocyclic ether compounds useful in controlling neurotransmitter release
    US-6538003-B1March 25, 2003Sanofi-SynthelaboPyridopyranoazepine derivatives, their preparation and their therapeutic application
    US-6809105-B2October 26, 2004Abbott LaboratoriesDiazabicyclic central nervous system active agents
    US-6833370-B1December 21, 2004Abbott LaboratoriesHeterocycle substituted aminoazacycles useful as central nervous system agents
    US-6919359-B2July 19, 2005Pfizer IncAzabicyclic-substituted-heteroaryl compounds for the treatment of disease
    WO-0007600-A1February 17, 2000R.J. Reynolds Tobacco CompanyCompositions pharmaceutiques de prevention et de traitement de troubles du systeme nerveux central
    WO-0071534-A1November 30, 2000Abbott LaboratoriesAminoazacycles heterocylcliques substitues utiles en tant qu'agents actifs sur le systeme nerveux central
    WO-0075110-A1December 14, 2000Targacept, Inc.Pharmaceutical compositions and methods for use
    WO-0162736-A1August 30, 2001Pfizer Products Inc.Aryl fused azapolycyclic compounds
    WO-02100826-A2December 19, 2002Cytovia, Inc.Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs
    WO-2004018607-A2March 04, 2004The Procter & Gamble CompanyMethod for maufacturing liquid gel automatic dishwashing detergent compositions comprising anhydrous solvent
    WO-2006047392-A2May 04, 2006The Trustees Of Columbia University In The City Of New YorkNicotinic-opioid synergy for analgesia
    WO-2006086068-A1August 17, 2006The Regents Of The University Of CaliforniaLabeled alpha-4-beta-2 ligands and methods therefor
    WO-2006096358-A1September 14, 2006Eli Lilly And CompanyDérivés d’azabicycloalcane utiles en tant qu’agonistes du récepteur nicotinique de l’acétylcholine
    WO-2006114400-A1November 02, 2006Neurosearch A/SNouveaux derives d'oxadiazole et usage medical de ceux-ci
    WO-9640682-A1December 19, 1996Abbott Laboratories3-pyridyloxyalkyl heterocyclic ether compounds useful in controlling chemical synaptic transmission
    WO-9910338-A2March 04, 1999University Of FloridaBenzylidene- and cinnamylidene-anabaseines as neuronal nicotinic alpha-7 receptor agonists
    WO-9932480-A1July 01, 1999Abbott LaboratoriesHeterocyclic ether and thioether compounds useful in controlling chemical synaptic transmission
    WO-9965876-A1December 23, 1999R.J. Reynolds Tobacco CompanyAryl substituted olefinic amines and their use as cholinergic receptors agonists

NO-Patent Citations (25)

    Title
    BITNER RS; NIKKEL AL; CURZON P; DONNELLY-ROBERTS DL; PUTTFARCKEN PS; NAMOVIC M; JACOBS IC; MEYER MD; DECKER MW, BRAIN RES., vol. 871, 2000, pages 66 - 74
    BUNDGAARD, E.,: "Design of Prodrugs", 1985, ELSEVIER SCIENCE PUBLISHERS
    CHAPIAN SR; BACH FW; POGREL JW; CHUNG JM; YAKSH TL, J NEUROSCI METHODS, vol. 53, 1994, pages 55 - 63
    CUCCHIARO G; CHAIJALE N; COMMONS KG, J PHARMACOL EXP THER, vol. 313, 2005, pages 389 - 394
    CURTIS L; BUISSON B; BERTRAND S.; BERTRAND D, MOLECULAR PHARMACOLOGY, vol. 61, 2002, pages 127 - 135
    CURTIS L; BUISSON B; BERTRAND S; BERTRAND, D., MOLECULAR PHARMACOLOGY, vol. 61, 2002, pages 127 - 135
    DECKER ET AL., CURR TOPICS MED CHEM, vol. 4, 2004, pages 369
    DECKER MW; MEYER MD; SULLIVAN JP, EXPERT OPINION ON INVESTIGATIONAL DRUGS, vol. 10, 2001, pages 1819 - 1830
    DECKER, MW; RUETER, LE; BITNER, RS: "Nicotinic acetylcholine receptor agonists: a potential new class of analgesics", CURR TOP MED CHEM., vol. 4, 2004, pages 369 - 384, XP002519705, DOI: doi:10.2174/1568026043451447
    FERREIRA M; SINGH A; DRETCHEN KL; KELLAR KJ; GILLIS RA, J.PHARMACOT.EXP. THER, vol. 294, 2000, pages 230 - 238
    ISOBE, T.; ISHIKAWA, T, J. ORG. CHEM., vol. 64, 1999, pages 6989 - 6992
    KHAN IM; WENNERHOLM M; SINGLETARY E; POLSTON K; ZHANG L; DEERINCK T; YAKSH TL; TAYLOR P, J NEUROCYTOL., vol. 33, 2004, pages 543 - 556
    KIM SH; CHUNG JM, PAIN, vol. 50, 1992, pages 355
    LAURETTI, G.T., EXPERT REVIEWS IN NEUROTHERAPEUTICS, vol. 6, 2006, pages 613 - 622
    MARCH: "Advanced Organic Chemistry, 3rd ed.", 1985, JOHN WILEY & SONS, pages: 1157
    MARCH: "Advanced Organic Chemistry, 3rd Ed.,", 1985, JOHN WILEY & SONS, pages: 1152
    MARK ET AL.: "Encyclopedia of Chemical Technology", 1980, JOHN WILEY & SONS
    MARUBIO LM; ARROYO-JIMENEZ MD; CORDERO-ERAUSQUIN M; LENA C; LE NOVERE N; D'EXAERDE AD; HUCHET M; DAMAJ MI; CHANGEUX JP, NATURE, vol. 398, 1999, pages 805 - 810
    NARAHASHI T; MORIGUCHI S; ZHAO X; MARSZALEC W; YEH JZ, BIOL.PHARM.BULL., vol. 27, 2004, pages 1701 - 1706
    PASTERNACK, G.W., CLIN NEUROPAHARMCOL., vol. 16, 1993, pages 1
    RASHID MH; FURUE H; YOSHIMURA M; UEDA H, PAIN, vol. 125, 2006, pages 125 - 135
    REUTER, L.E.; ANDERSON, D.J.; BRIGGS, C.A.; DONNELLY-ROBERTS ET AL., CNS DRUG REV., vol. 10, no. 2, 2004, pages 167 - 182
    SOBOL, E.; BIALER, M; YAGEN, B., J. MED. CHEM., vol. 47, 2004, pages 4316 - 4326
    T.W. GREENE; P.G.M. WUTS: "Protective Groups in Organic Synthesis, 3rd edition", 1999, JOHN WILEY & SONS
    WANG, Y.; SAUER, D.R.; DJURIC, S.W., TETRAHEDRON. LETT., vol. 47, 2006, pages 105 - 108

Cited By (0)

    Publication numberPublication dateAssigneeTitle